CD44 and infantile convulsions and choreoathetosis: Morine et al. [57] further demonstrated that CD44+ iCCA patients exhibited a worse prognosis than the CD44- iCCA patients in terms of 5-year survival (19.3% vs. 55.5%), indicating that CD44 is an important marker and prognostic indicator for iCCA.